Discovery of small-molecule inhibitors targeting the ribosomal peptidyl transferase center (PTC) of .

(Mtb) is a pathogenic bacterium that causes tuberculosis, which kills more than 1.5 million people worldwide every year. Strains resistant to available antibiotics pose a significant healthcare problem.